A Study of the Outcome of Catheter Ablation for Atrial Fibrillation Complicated by Hypertrophic Cardiomyopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1020230057

Enrollment

Registered

2024-02-16

Start date

2024-02-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophioc cardiomyopathy Hypertrophic cardiomyopathy, atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hypertrophic cardiomyopathy who have undergone atrial fibrillation ablation at our hospital between January 2014 and March 2024. Gender is irrelevant; patients must be at least 20 years of age, but there is no upper age limit.

Exclusion criteria

Exclusion criteria: Patients who wish not to participate in this study.

Design outcomes

Primary

Measure	Time frame
Recurrence of atrial fibrillation.	—

Secondary

Measure	Time frame
Major adverse cardiovascular events	—

Contacts

Public ContactTakahiko Kinjo

Hirosaki University

kinjo1984@gmail.com+81-172395057

Outcome results